Oncology
5,770 studies495 in 7 days2,675 in 30 days
Filters
Latest
5,770 studies
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
- PARP inhibitors and newly second primary malignancies in cancer patients: a systematic review and safety meta-analysis of placebo randomized controlled trials
- Visceral metastatic angiosarcoma treated effectively with oral cyclophosphamide combined with propranolol
- Dramatic response of an inoperable Merkel cell carcinoma with imatinib
- Relative dose intensity of gemcitabine-nab-paclitaxel combination as second-line or more in locally advanced or metastatic pancreatic adenocarcinoma
- Relative dose intensity of first-line triplet chemotherapy in metastatic colorectal cancer
- Sotorasib plus panitumumab and 5-fluorouracil in first-line treatment of patients with unresectable KRAS G12C mutated colorectal cancer unfit for a doublet/triplet chemotherapy: ENGIC 01 – PRODIGE 107 – FFCD 2306 – COLOSOTO trial
- Evaluation of a colorectal cancer screening program composed of successive waves of different tests: The experience of the French Calvados County
- Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France
- NHS England breast screening: Who attends, and why? The influence of psychosocial and demographic determinants
- Net Renal Drug Secretion Critically Requires Significant Contribution of Basal Uptake Transporters: Perspective From Mechanistic Kidney Model Simulation and Integration of Clinical and In Vitro Data
- Correlation Analysis of Peripheral Blood Inflammatory Cell Markers With Obesity in Chronic Schizophrenia Patients
- Nanoparticle size governs engagement with myeloid cells and hitchhiking to hematopoietic organs in myeloproliferative neoplasms
- A stromal metabolic program suppresses NK-cell immunity to drive tumor progression in HER2-low breast cancer
- Neoadjuvant chemotherapy induces transient, regimen-specific immune stromal reprogramming in pancreatic ductal adenocarcinoma
- Remodelling of chromatin architecture and super-enhancer landscape in lamin A/C depleted HGSOC
- The CD112-TIGIT/PVRIG Axis Mediates NK Cell Evasion inDecitabine-Treated Acute Myeloid Leukemia Cells
- Distinct atypical chemokine receptor 1 determinants underlie bacterial toxins recognition and pore formation
- A Distal Super-Enhancer Regulate CD47 Expression and Promotes Macrophage-Mediated Phagocytosis of Ovarian Cancer Cells
- Impact of Trastuzumab and Pertuzumab on HER2 Localization and the Estrogen Receptor Cistrome in ER+/HER2+ Breast Cancer
- Transcriptomic FOLFIRINOX sensitivity signatures stratify overall survival and reveal directional reclassification after neoadjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic cancer
- One-Carbon Metabolic Reprogramming Stratifies Prognosis and Defines Distinct Biological States in IDH1-Mutant Gliomas
- Lung-Reporting and Data System Category (Lung-RADS) and Adherence to Low-Dose Computed Tomography Screening and Recommended Follow-Up: A Multicenter Cohort Study
- Pharmacogenomic predictor of long-term residual chemotherapy-induced peripheral neuropathy in ovarian cancer survivors: A substudy of the GINECO Vivrovaire study
- Factors Associated With Receipt of Adjuvant Radiation in Locally Advanced Rectal Cancer